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We describe the identification of point mutations in the androgen
receptor gene in five Brazilian patients with female assignment and
behavior. The eight exons of the gene were amplified by the poly-
merase chain reaction (PCR) and analyzed for single-strand confor-
mation polymorphism (SSCP) to detect the mutations. Direct se-
quencing of the mutant PCR products demonstrated single transitions
in three of these cases: G→A in case 1, within exon C, changing codon
615 from Arg to His; G→A in case 2, within exon E, changing codon
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Male pseudohermaphroditism is charac-
terized by deficiency or absence of viriliza-
tion in genetically male individuals (46,XY)
with intra-abdominal or inguinal testes (1).
The androgen insensitivity syndromes (AIS)
are X-linked disorders which result from
defects in the androgen receptor (AR) and
are the most frequent cause of male pseudoher-
maphroditism. Phenotypic expression of AIS
is quite variable: the complete form is char-
acterized by a female phenotype while par-
tial forms may be found in undermasculinized
males or in normal males with infertility (2).
The AR is a member of the steroid hor-
mone receptor superfamily of ligand-depend-
ent transcription factors, and its protein com-
prises 919 amino acids. The androgen recep-
tor gene is localized in the Xq11-12 region,
spanning 90 kb and its approximately 2757-
bp coding region is organized in 8 exons.
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The complete cDNA sequence consists of
3.6 kb. The AR protein is divided into three
distinct functional domains: the N-terminal
domain (exon A), that has a role in transcrip-
tional activation, the central domain (exons
B and C), which consists of two zinc-finger
elements responsible for DNA binding, and
the C-terminal domain (exons D through H),
responsible for androgen binding (3).
The heterogeneity in the phenotypic ex-
pression of AIS is due to a variety of andro-
gen gene mutations which include deletions
and point mutations, with the latter causing
amino acid substitutions, premature termi-
nation of transcription and inappropriate
splicing of RNA (4).
In the present study we report the results
of molecular analysis of the androgen recep-
tor gene in five unrelated subjects with a
clinical diagnosis of complete androgen in-
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sensitivity syndrome (CAIS). The five pa-
tients (Table 1) presented normal female
external genitalia but a male karyotype
(46,XY). Physical and hormonal features
were consistent with CAIS and the gonads
were testes.
Genomic DNA was isolated from patient
leukocytes by standard methods. The eight
exons of the gene were amplified by the
polymerase chain reaction (PCR) and
screened for single-strand conformation poly-
morphism (SSCP) to identify mutations. PCR
was performed using 11 sets of primers (5,6).
The exon A coding sequence was subdi-
vided into four overlapping fragments due to
its large size (1613 bp).
Since SSCP is more sensitive for frag-
ments of less than 350 bp, the PCR products
of the three fragments from exon A and from
exon D were cleaved with appropriate re-
striction enzymes prior to electrophoresis.
The denatured PCR products were run on
non-denaturing 12.5 and 20% polyacrylamide
Phastgel in the absence of glycerol using the
Pharmacia PhastSystem (Uppsala, Sweden).
Electrophoresis was carried out at either 15
or 20oC for 2 h at 150 V, and the gels were
silver-stained.
Band-shifts in SSCP gels were detected
in three cases, on exons B, C and E. Direct
sequencing was performed with PCR prod-
ucts from two separate reactions using the
sense and antisense primers labelled with γ
P32-ATP and the Thermosequenase kit
(Amersham Life Science Inc., Cleveland,
OH). The sequencing of the putative mutant
segments revealed G→A transitions in two
instances: at position 2348 (exon C) in case
1, resulting in the Arg615His substitution
(Figure 1A), and at position 3136 (exon E) in
case 2, resulting in the Arg752Gln substitu-
tion (Figure 1B). In case 3, a cytosine to
thymine mutation at nucleotide 1989 (exon
B) was found, but this substitution did not
result in amino acid changes (Ala585Ala).
We have encountered some difficulties
in the amplification and SSCP analysis of
exon A, since these regions contain a highly
polymorphic polyglutamine (CAG) stretch
and a highly GC-rich segment encoding a
polyglycine stretch. Two polymorphisms
were studied in this exon: the number of
CAG repeats and the StuI restriction enzyme
polymorphism (7,8). The number of CAG
repeats varied from 18 to 24, being within
the normal range (9). The analysis of StuI
polymorphism showed that all patients were
positive for this restriction enzyme site, which
is the most frequent allele in American Cau-
casian males (8).
To date, 245 mutations were described in
the androgen receptor gene that give rise to
AIS. A regular data base has been compiled
and updated by Gottlieb et al. (10) and is
available from EMBL (http://www.mcgill.ca/
androgendb).
Most of the mutations identified in the
AR gene are different, with very few patients
sharing the same mutation. The same muta-
tion can be associated with different pheno-
types not only from different families but
even within the same family. The distribu-
tion of androgen receptor gene mutations is
interesting also for the clustering of muta-
tions in specific areas of the receptor protein
in or around exons E and G, as well as for the
paucity of mutations that have been local-
ized on exon A. Only mutations in exons B
and C have an expected phenotype, which is
almost always related to CAIS (11).
The Arg615His substitution (case 1) has
already been described in CAIS patients (12-
Table 1 - Age at diagnosis and familial recurrence
status of the five CAIS patients.
*One of the two maternal aunts of subject 5 was
previously examined by us.
Subject Age (years) Familial recurrence
1 26 sister and maternal aunt
2 16 none
3 21 sister and maternal aunt
4 14 none
5 2 two maternal aunts (*)
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15). This mutation prevents the androgen
receptor from binding the androgen respon-
sive element (ARE) consensus and abol-
ishes its transactivational competence in vi-
tro, being probably sufficient to cause com-
plete AIS (13).
The Arg752Gln substitution (case 2) has
also been detected in patients from two fami-
lies (16,17). Evans (16) reported the absence
of hormone-receptor binding on genital skin
fibroblasts from one of these patients. Ac-
cording to this author, this mutation is iden-
tical and functionally equivalent to that ob-
served at amino acid 734 of the rat androgen
receptor in rat testicular feminization. Muta-
tions in exon E represent about 40% of all
molecular alterations involving amino acid
changes described in the hormone-binding
domain (3).
Since the detection rate for SSCP is esti-
mated to be 70 to 80% (6), exons B to H from
cases 3, 4 and 5 were completely sequenced
to exclude the existence of mutations in these
regions, and none were found. However,
undetected mutations may still exist in exon
A, not sequenced in this study, or may be
related to the androgen receptor gene pro-
moter (18). Somatic mosaicism may also be
postulated since genomic DNA was isolated
from leukocytes, and not from tissues where
the AR gene is expressed, like genital skin
(19).
There is still the possibility that some
mutations were missed by the screening pro-
cedure, although some cases may be the
result of other, as yet undefined, genetic
lesions (20).
Figure 1 - Non-isotopic SSCP
(left) and sequencing analysis
(right) of patients 1 (A) and 2 (B).
The sequence numbering
adopted was that established by
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